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ABSTRACT
Introduction: Entrobacteriaceae is a large family of gram-negative bacteria and common
cause of nosocomial infection. Beta–lactam antibiotics are the possible drugs for
infections caused by entrobacteriaceae. But they produce extended spectrum beta-
lactamases that cause high resistance to the beta-lactam antibiotics.
Objective: To assess the magnitude of extended spectrum beta-lactamase producing
entrobacteriaceae in Gondar Referral Hospital environment.
Methods: A cross sectional study was carried out at the University of Gondar Referral
Hospital from January to June 2014. A total of 384 environmental samples were taken
from inanimate objects and waste water from sewage. The samples were cultured onto
MacConkey agar, then species was identified by biochemical tests and isolates were also
subcultured on to Hicrome ESBL agar base to assess ESBL production. Antimicrobial
susceptibility tests were done using the disc diffusion method. Data was entered in SPSS
version 20 statistical software and analysed. The result was presented in table, figures and
text.
Result: From a total of 384 samples, 163 (42.45%) entrobacteriaceae were isolated and
of which 57(35.0%) were ESBL producing entrobacteriaceae. The most common ESBL
producing isolates were Klebsiella pneumoniae 24 (14.7%) followed by Escherchia coli
20 (12.3%) and Proteus mirabilis (2.4%). Most of ESBL producing isolates were from
waste water 14 (24.6%), sink 13 (22.8%) and bed side table 13(22.8). All ESBL
producing entrobacteriaceae were resistant to ceftriaxone, ceftazidime, cefpirome,
cefpodoxime and augmentin. Also resistant to chloramphenicol, 40(70.2%),
cotrimoxazole, 37(64.9%), norfloxacilin, 24(42.1%), ciprofloxacilin 25(43.9%),
gentamicin, 11(19.1%).
Conclusion: ESBL producing entrobacteriaceae were isolated from hospital
environments. Klebsiella pneumoniae, Escherchia coli & Proteus mirabilis were
predominant ESBL producing. It is important that health professional and other workers
should take an active role in infection control and encourage good antibiotic prescribing
practice.
Key words: ESBL, Entrobacteriaceae, Hospital Environment
11. INTRODUCTION
Hospital environment is a potential source of nosocomial infections, since it houses both
patients with diverse pathogenic microorganism and large number of susceptible
individuals. Nosocomial infections are infections that have been caught in hospital and
are potentially caused by organisms that are resistant to multiple antimicrobial agents.
The emergence of multi-drug resistant organisms in hospital results in a problem to treat
nosocomial infections (1).
The ever-increasing bacterial resistance to antibiotics is one of the most challenging tasks
of all the medical issues today (2). Persistent exposure of the bacterial strains to multitude
of beta-lactamases has induced a dynamic and continuous production and mutation of
beta-lactamases in the bacteria. This leads to the development of extended spectrum beta-
lactamases (ESBLs) which cause resistance to broad spectrum beta-lactam antibiotics.
This resistance mechanism has been responsible for nosocomial as well as community out
breaks and cause of serious therapeutic failure (3).
Extended spectrum beta-lactamase is plasmid-mediated enzymes hydrolysing most
penicillins and cephalosporins, including oxyimino-beta-lactam compounds (cefuroxime,
third and fourth-generation cephalosporin and aztreonam) but not cephamycins and
carbapenems. The Ambler molecular classification and the Bush-Jacoby-Medeiros
functional classification are the two most commonly used classification systems for β-
lactamases. Ambler scheme divides β-lactamases into four major classes (A to D). The
basis of this classification scheme rests upon protein homology (amino acid similarity)
and not phenotypic characteristics. In the Ambler classification scheme, β-lactamases of
classes A, C and D are serine β-lactamases. In contrast, the class B enzymes are metallo-
β-lactamases. With the exception of OXA-type enzymes (which are class D enzymes), the
ESBLs are of molecular class A. Most ESBLs belong to the Ambler class A of beta-
lactamases and are inhibited by beta-lactamase inhibitors (clavulanate, sulbactam and
tazobactam) (3, 4).
According to National Committee for Clinical Laboratory Standards (NCCLS) now
Clinical and Laboratory Standards (CLSI) interpretive definitions of ESBLs do not
always increase MICs to levels characterized as resistant. Now, it is mandatory that the
routine clinical microbiology laboratory employs ESBL detection methods which are
sensitive enough to recognize the level of resistance that would be achieved by the
2situation given in vivo. The methods for detection of ESBLs can be broadly divided into
two groups: phenotypic methods that use non-molecular techniques, which detect the
ability of the ESBL enzymes to hydrolyse different cephalosporins; and genotypic
methods, which use molecular techniques to detect the gene responsible for the
production of the ESBL. Clinical diagnostic laboratories use mostly phenotypic methods
because these tests are easy to do, are cost effective, and have been incorporated in most
automated susceptibility systems, making them widely accessible. However, phenotypic
methods are not able to distinguish between the specific enzymes responsible for ESBL
production (SHV, TEM, and CTX-M types). The detection of ESBL-producing bacteria
in laboratories is a crucial step for appropriate management of patients (4,5).
The first ESBL-producing strains were identified in 1983, and since then have been
observed worldwide (4). This distribution has been due to the clonal expansion of
producer organisms and the horizontal transfer of their genes. By far the most important
groups of ESBLs are Cefotaximase, munich (CTX-M) enzymes, followed by Sulphydryl
Variable (SHV) and Temoneira (TEM) derived ESBLs. Certain Oxacillin (OXA) derived
enzymes are also included within ESBLs, although inhibition by class A-beta-lactamase
inhibitors is weaker than for other ESBLs (5).
Rates of CTX-M infections have increased during the last decade compared with rates of
TEM and SHV infections (6). These enzymes confer resistance to beta-lactam
antibacterial drugs, particularly cephalosporin, and may be accompanied by co-resistance
to drugs of other classes. Because of the ESBL resistance and associated co-resistance,
empiric oral antibacterial therapy appears to be limited, especially in the community
settings (7).
Extended spectrum beta lactamase production has been observed mostly in
entrobacteriaceae and its resistance increased mainly due to the spreading of ESBL, and
also different genes are emerged (8). Resistance genes of the ESBL type are mostly
plasmid associated and therefore can spread among bacteria and it can lead to the overall
distribution of antimicrobial resistance. This resistance increases morbidity and mortality
in infected individuals by hampering the adequate provision of effective chemotherapy
(9).
The most frequently encountered members of ESBL-producing entrobacteriaceae are
Escherichia coli, K. pneumoniae, and Proteus spp. However, all other clinically relevant
3entrobacteriaceae species are also common ESBL producers. The prevalence of ESBL
positive isolates depends on a range of factors including species, geographic locality,
hospital or ward, group of patients and type of infection, and large variations have been
reported in different studies (10, 11).
Extended spectrum beta lactamase resistance pattern was initially considered as a problem
related to nosocomial out break, mainly in Intensive Care Units (ICUs), that is, recent
surgical procedures, use of catheters, bladder catheterization, long-term hospitalization
and previous use of cephalosporins or amino glycosides (12). However, the distribution of
ESBL producing entrobacteriaceae have been become very common in almost any other
area of hospital which indicates high possibility of horizontal gene transfer among strains
of different genera within the hospital environment (13,14,15).There is shortage of report
about ESBL producing entrobacteriaceae at hospital environment in Northwest Ethiopia.
Therefore, the aims of this study were to assess and determine the rate of ESBLs
producing entrobacteriaceae in the hospital environment at University of Gondar Referral
Hospital.
42. LITERATURE REVIEW
2.1. Distribution of Entrobacteriaceae in inanimate objects of the hospital
Environment
Different studies in various parts of the world had assessed the extents of
entrobacteriaceae contamination in the hospital environment. A cross sectional study in
Nigeria was conducted and samples were obtained from doctors, nurses, orderlies,
patients, air and fomites like beds, cannula, oral thermometer and table. A total of 56
bacteria were isolated. Gram negative bacilli were one part of isolate and among these,
Escherichia coli were the highest (4; 7.1%). Others were Klebsiella pneumoniae (3;
5.3%), Proteus spp. (2; 3.5%) and Entrobacter aerogenes (2; 3.5%) (16).
Another cross sectional study was conducted at the university of Gondar teaching
hospital from November 2010 to February 2011, on a total of 220 samples. Out of these
142 swab samples were collected from various hospital environments such as medical
devices, inanimate objects and air in different areas (56 located in the operating room, 42
in surgical and 44 in orthopaedic wards) and other samples were pus, nasal and hand
swabs. In inanimate objects, 142(52.9%) organisms were isolated and 41(28.9%) were
gram negative. Out of these, Klebsiella species 11(26.8%), Escherichia coli 10(24.3%),
Proteus species 5(12.2%) and Entrobacter 4(9.8%) were common among gram negative
isolates. Citrobacter 2(4.9%), Serrattia 1(2.4%) were the least isolated. The hospital
environment that had the highest number of bacterial isolates was the operating rooms
but orthopaedic ward did not show any bacterial growth even after 24 hours of incubation
(17)
52.2. Distribution of extended spectrum beta–lactamase producing entrobacteriaceae
in inanimate objects of the hospital environment
Beta-lactam antibiotics are the most common drugs against entrobacteriaceae infections
and on the other hand the emergence of resistance to extended spectrum cephalosporin
has become a major concern to see this beta-lactam resistance (2, 14).
A study in France had also evaluated surface contamination on five standardized sites
surrounding patients who were infected or colonized with ESBL producing Klebsiella
species, (n=48) or ESBL producing E.coli (n=46). Environmental contamination was
significantly more likely in the rooms of Klebsiella species patients (31% of 48 rooms
positive; 6% of 240 sites positive) vs E.coli patients (4% of 46 rooms positive, 1% of
230 sites).The result was only 52% of the ESBL producing isolates were identical to the
patients in the room, suggesting survival of ESBL producing bacteria to the prior
occupants in to the room (18).
Another study was done in Auckland, Newzeland to measure the difference in hospital
contamination rates between ESBL-producing Klebsiella pneumonia (ESBL-KP) and
Escherichia coli (ESBL-EC) and to identify risk factors for contamination of the hospital
environment with these organisms. Samples were collected in 8 surfaces in the rooms and
bathrooms of adult patients colonized or infected with ESBL-EC or ESBL-KP throughout
their hospital stay, that is blood pressure cuff, the nurses call bell, the top of patients bed
side cabinet, the patient’s over bed tray table, the toilet seat, the hand rail next to the
toilet, basin tap in the bathroom and the bathroom’s inside door handles. The overall
contamination rate was 3.4%(38/1104) and was significantly higher for ESBL-KP than
ESBL-EC (5.4% versus 0.4%; p < 0.0001),and antimicrobial susceptibility profiles were
consistent between corresponding patient and environmental isolates without exception
(19) .
A study in Australia, bacteria was isolated from patients with Health Acquired Infections
exhibiting resistance to beta-lactam antibiotics over a one month period in 2011. All
sampled patients were in a 14-bed burns unit and the environmental sample sites included
shower drains, sinks, trolleys, and door handles. It was found that identical strains
6carrying the same resistance regions were present in both patients and the hospital
environment suggesting Health Acquired Infections can arise from bacteria resident in
the immediate surrounds (20).
Study in Algeria, which was done in the Intensive Care Unit of Tlemcen University
Hospital to identify and screen ESBLs isolates by API 20E and DDST respectively from
19 October to 23 November 2008. The result of the study was 2 cefotaxime-resistant
isolates (K. pneumonia and Entrobacter cloaceae) which were recovered from surfaces of
the ICU. Minimum inhibitory concentrations (MIC) of cefotaxime and ceftazidime were
from 64 to 512mg/dl and 4 to 128mg/dl respectively (21).
There was also another study in Upper Egypt to evaluate the rate of environmental
contamination of extended spectrum beta lactamase and ESBL producing Klebsiella
pneumoniae and Eschericia coli as well as the susceptibility to 13 antimicrobial agents. A
total of 227 environmental isolates, K.pneumoniae (n=102) and E.coli (n=125) were
recovered from750 samples of 6 different environmental surfaces. ESBL production was
observed in 80 isolates, for overall prevalence of 56.25% with a predominance of
K.pneumoniae (45/80), followed by E.coli prevalence of 43.75 with predominance of
(35/80). The resistance rate was higher among ESBL producers than non ESBL
producers. All of K.pneumoniae and E.coli ESBL producers were found resistance
(100%) to cephalotin, ampicillin, cefataxine, cefuroxime, ceftriaxone and ceftazidime.
The resistance rate (%) was higher in azetreonam (93.3 and 100) and ceftazidime (95.5
and 91.42) then gentamicin (84.4 and 42.8) ciprofloxacilin (77.7 and 68.5) followed by
cotrimoxazole (46.6 and 60) of ESBL producing Klebsiella pneumoniae and Eschericia
coli strains, respectively (22).
There was study in Egypt, the Zagazig University Hospitals, in paediatric department to
determine extended spectrum beta-lactamase producing Klebsiella pneumoniae in
Neonatal Intensive Care Unit. From 343 environmental cultures taken from potential
sources of infection, 8 isolates (2.3%) of K. Pneumonia were identified; 4 from suction
tubes, 2 from the incubators and 2 isolates from the hands of Health Care Workers (23).
72.3. Distribution of Entrobacteriaceae in waste water in hospital sewage system
Different studies were done in waste water for a reservoir of different organism which
infects the general population in the community.
One cross-sectional study was conducted at Gondar from January – June 2012. The waste
water was collected from hospital sewage system of different sections of the Gondar
university teaching hospital and non –hospital environment. A total of 60 waste water
samples were processed and 113 bacterial isolates were recovered. Out of these 65
(57.5%) were from hospital environment and 48 (42.5%) were non-hospital environment.
The most frequently identified bacterium in hospital waste water was Klebsiella spp.
11(22.9%) , E. coli 5(10.4%) and Citrobacter spp 8(16.7%) (24).
2.4. Distribution of ESBL-producing entrobacteriaceae in waste water in hospital
sewage system.
Waste water contains high amount of resistant bacteria strains and antibiotic residues at a
concentration able to inhibit the growth of susceptible bacteria which introduces into the
sewage system that come from hospital (25, 26).
A study in three hospitals in poland, ESBL producing Entrobacteriaceae was investigated
in 63 sewage samples. In the group of 310 randomly sampled strains isolated from
hospital effluents, 295 (95.2%), 253 (81.6%), and 228 (73.5%) isolated were resistant to
cefotaxime, ceftazidime and cefpodoxime, respectively (27).
A study was also done in Alexander, Egypt, from December 2012 and April 2013. The
result of the study shows the existence of ESBL producing entrobacteriaceae in waste
water. Waste water samples were collected; one from influent waste water (raw sewage)
going into the treatment plant and other one from the effluent waste water after treatment.
The result was show existence of ESBL producing Entrobacteriaceae and it was slightly
higher in influent (69.8%) than effluent flow (57.7%). A total of ESBLs producing E.coli
(74 isolates) and K. pneumonia (13 isolates) were identified (23). The bacterial isolates
show highest antimicrobial resistance rates to amoxacilin-clavulanic acid, piperacillin-
tazobactam and trimethoprim/sulfamethoxazole (28).
83. SIGNIFICANCE OF THE STUDY
Extended-spectrum beta lactamase producing entrobacteriaceae are an increasing
challenge for health care practitioners while they are fighting health care-associated
infections (HAIs). They have been responsible for numerous outbreaks of infections
throughout the world. The outcomes of clinical data indicate that ESBLs are clinically
significant because of their resistant genes which are usually present in the hospital and
can reach the environment which finally lead to limited therapeutic option (9).
However, there is limitation of study in the area which addresses this issue to the health
care personnel and community. Therefore, this study tries to show the distribution of
extended spectrum beta-lactamase producing entrobacteriaceae, to identify the dominant
ESBL producing isolates and to determine resistant pattern of isolates to the commonly
used antibiotics in the hospital which may be important as first hand information in
infection control and rational use of drugs in the hospital.
94. OBJECTIVE
4.1. General Objective
 To assess the prevalence and antimicrobial susceptibility patterns of extended
spectrum beta-lactamase producing entrobacteriaceae at the University of Gondar
Hospital Environment, Gondar, Northwest Ethiopia.
4.2. Specific Objectives
 To determine the prevalence of extended spectrum beta lactamase producing
entrobacteriaceae..
 To determine the antimicrobial susceptibility pattern of extended spectrum beta
lactamase producing entrobacteriaceae to the commonly used antibiotics in the
hospital.
.
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5. MATERIAL AND METHODS
5.1. Study area and period
The study was conducted at the University of Gondar Referral Hospital from January to
June 2014.University of Gondar Referral Hospital is found in Gondar town in Northwest
Ethiopia. The town is located at 748 km away from Addis Ababa, the capital city of
Ethiopia. The town is situated at an altitude of 2200 m above sea level and total annual
rainfall of 1800mm and an average temperature ranging from 14oc-28oc. University of
Gondar Referral Hospital provides surgical ,medical, paediatric, gynaecologic, obstetric
and ophthalmologic services to the community of over 5 million inhabitants. The hospital
consists of 19 wards with 465 beds and outpatient departments.
5.2. Study design
A hospital based cross sectional study.
5.3. Source of population
The source populations were inanimate objects and waste water from sewage system of
the hospital.
5.4. Study population
The study population was taken from taken from environmental surfaces (bed frames,
bed side tables, floors, walls, sinks, door handles, and waiting chairs) of the hospital
which are directly related to patients and patient family. Hence the focused areas are the
intensive care unit, emergency, orthopaedic room, surgery, delivery ward, Out Patient
Department(OPD), Maternal and Child Health (MCH), laboratory and pharmacy
dispensing area. Waste water in sewage system of the hospital environment and chairs in
hospital cafe were part of the population of the study.
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5.5. Sample Size and Sampling techniques
Sample size Determination
The sample size was determined by using single population proportion formula. The
population proportion of a target population with a certain characteristics is 0.5 (50%),
desired accuracy of 0.05 at 95% confidence interval (Z statics=1.96), then the sample size
was
n= Z2p (1-p)/d2,
n= (1.96)2(0.5) (1-0.5)
(0.05)2
= 384
These samples include surfaces of floors, bed frames, bed side tables, door handles,
walls, sinks, waiting chairs in intensive care unit, emergency room, surgery, orthopaedic,
delivery, laboratory room, pharmacy dispensing area and waste water from hospital
sewage system.
Sampling Techniques
In the hospital, 26 sites were identified to collect environmental specimens. In order to set
sample distribution per site, a factor ‘K’ was used to calculate proportion of populations
in the selected hospital environment. Finally a simple random sampling technique was
used to select the study population. However, the total number of waste water source was
used as sample size of waste water because it’s sample was very small. Total population
to be sampled were 2508 and the actual sample size were 384.The “K” factor is used for
the calculation used to get size of each type of sample from the total were calculated as
384/2508=0.15.
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Figure: Schematic presentation of sampling procedure
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5.6. Operational Definition
Extended Spectrum beta lactamase: - is an enzyme that hydrolyses the beta lactam
ring of penicillins and cephalosporins, including oxyimino-beta-lactam compounds
(cefuroxime, third and fourth-generation cephalosporins and aztreonam) but not
cephamycins and carbapenemes.
Environmental swab: A swab specimen that is taken from inanimate objects from
different section of the hospital.
Hospital environment: is the area of hospital which is allocated by individual (patients,
non-patients), medical devices, bed frames, bed side tables, sections (wards), floor, walls,
sinks, sewage, toilet, pipes waiting chair and cafe chair.
Hospital inanimate objects: is a material found in hospital for different activities, like,
bed frames, bed side tables, floor, walls, sinks, sewage, toilet, pipes waiting chair and
cafe chair.
Hospital sewage sample: is waste water in solution or suspension that is intended to
be removed from different section of the hospital.
5.7. Study variable
Dependent variables
 Extended spectrum beta lactamase producing entrobacteriaceae
 Drug susceptibility pattern (susceptible, intermediate, resistance)
Independent variables
 Surfaces of floor, bed frames, bed side tables, door handles, walls, sinks, waste
water, waiting chairs and hospital cafe chairs.
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5.8. Data collection and processing
5.8.1. Specimen collection
A total of 384 environmental samples were collected from hospital inanimate objects
and waste water from different hospital sewage system. Sterile cotton tipped swabs
moistened with normal saline was rotated against the surfaces of in animate objects to
obtain specimens. Samples were aseptically collected using sterile test tubes and sterile
cotton swabs for surface sampling and waste water was collected from sewage system of
the hospital by sterile screw capped bottle and was transported to Microbiology
Laboratory. Each sample was transferred to the appropriate media within 2 hours (30).
5.8.2. Sample processing
5.8.2.1. Isolation
Swabs of surfaces and loop full of waste water were inoculated on MacConkey agar and
the inoculated agar plates were incubated at 37oc for 24 hours and growth was inspected.
Identifications of the isolates were done by performing a series of biochemical tests and
isolates of entrobacteriaceae were sub-cultured onto Hicrome ESBL agar base for
phenotypic detection of ESBL producing species. Antimicrobial susceptibility tests were
done for other commonly used antibiotics following disk diffusion method (29,30)
5.8.2.2. Identification
ESBL producing entrobacteriaceae was identified based on colour of colonies. That is
E.coli produces pink or purple colonies. ESBL producing members of the
entrobacteriaceae such as Klebsiella, Enterobacter, Serratia, Citrobacter species produce
bluish green colonies and Proteus, Morganella and Providencia do not utilize any
chromogen resulting in colourless to light brown colonies (32). Biochemical tests were
performed on colonies from primary cultures for final identification of the isolates.
Biochemical tests such as indole production, sugar fermentation, H2S production, gas
production, citrate utilization, motility test, urease test, oxidase were used to identify
entrobacteriaceae isolates up to species (30).
15
Susceptibility testing was performed on isolates based on the agar disk diffusion
techniques. That is from a pure culture 3-5 selected colonies of   bacteria were taken
and transferred to a tube containing 5ml sterile nutrient broth (Oxoid) and mixed gently
until a homogenous suspension was formed  and  incubated at 37OC until the turbidity of
the suspension become adjusted to a McFarland 0.5 (30).
A sterile swab was dipped into the suspension of the isolate in broth, squeezed free from
excess fluid against the side of bottle. The test organism was uniformly seeded over the
Mueller-Hinton agar. The antimicrobial susceptibility patterns of the test organism were
evaluated against. ceftazidime(30µg), ceftriaxone(30µg), cefpodoxime(10µg),
cefpirome(30µg), amoxacillin with clavulanic acid (agumentin) (30µg) ciprofloxacin
(5µg), norfloxacillin (10µg), sulfamethoxazol/trimethoprin (1.25/23.75µg), Gentamicin
(10µg) and chloramphenicol (30µg). The medium was then incubated at 37oc for 18-
24 hours. Then   zone of inhibition around the discs was measured to the nearest
millimeter using a metal caliper, and the isolates were classified as susceptible,
intermediate and resistant (31).
5.9. Quality Control
The reliability of the study finding was guaranteed by implementing quality control
measures throughout the whole processes of the laboratory works. All materials,
equipments and procedures were adequately controlled. Culture Medias were tested for
sterility and performance. Pre-analytical, analytical and post-analytical stages of quality
assurance that are incorporated in standard operating procedures of the microbiology
laboratory of University of Gondar were strictly followed. Escherichia coli (NCTC
13351), Klebsiella pneumoniae (ATCC 700603) and Candida albicans were used in
controlling the testes carried out in this study. The inoculums density of bacterial
suspension for the susceptibility test was standardizing by using 0.5McFarland standard
(32).
16
5.10. Data Analysis
Data were entered into SPSS version 20 statistical software package for analysis.  The
data was analyzed using descriptive statistics. The result was presented in the form of
tables, figures and texts using frequencies and summary statics such as percentage to
describe the study population in relation to relevant variables.
5.11. Ethical Consideration
Ethical clearance was obtained from Research and Ethical Review Committee of the
School of Biomedical and Laboratory Sciences, College of Medicine and Health
Sciences, University of Gondar. Official permission was obtained from University of
Gondar Hospital management. The purposes and the importance of the study were
explained and its confidentiality was maintained at all level of the study.
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6. RESULTS
6.1. Distribution of Environmental samples
In this study, a total of 384 specimens were collected from various sources, surfaces of
inanimate objects and waste water from different sewage system hospital were used as
shown in table1.
Table1. Distribution of environmental samples per different sites at University of
Gondar Referral Hospital, Northwest Ethiopia, January to June2014.
Type of
Sample
Number (%)
Site of the hospital, n(%)
Wards
N=20
Pharmacy
N=4
Laboratory
N=4
OPD
N=16
Cafe
N=1
Bed side table 70(18.2) 57(14.8) - - 13(3.4) -
Bed frame 69(18) 56(14.5) - - 13(3.4) -
Floor 69(18) 56(14.5) - - 13(3.4) -
Wall 69(18) 56(14.5) - - 13(3.4) -
Door Handles 34(8.9) 28(7.2) 2(0.5) 2(0.5) 2(0.5) -
Sink 22(5.7) 18(4.6) 1(0.2) 1(0.2) 2(0.5) -
Waste water 15(3.9) 13(3.4) - 2(0.5) - -
Waiting chair 31(8.1) 26(6.8) - - 5(1.3) -
Cafe chair 5(1.3) - - - - 5(1.3)
6.2 Distribution of Entrobacteriaceae in the hospital environments
A total of 163(42.45%) entrobacteriaceae were isolated from the hospital environment,
bed side tables, bed frames, floors, walls, door handles, sinks, waste water, waiting chairs
and cafe chairs during the study period. Of all isolates, 106(65.0%) were non-ESBL
producers and 57(35.0%) were ESBL producing of entrobacteriaceae. E.coli 82
(50.3%) was the most common isolates followed by K.pneumoniae 60 (36.8%),
P.mirabilis 5(3.1%) and E.aerogens 5 (3.1%). The most common species of
entrobacteriaceae that produce ESBL were K.pneumoniae (42.1%) followed by E.coli
(35.1%) and P.mirabilis (7.0%) (Table 2).
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Table2. Isolates of entrobacteriaceae in hospital environments at University of
Gondar Referral Hospital, Northwest Ethiopia, and January to June2014.
Bacterial isolates Number N (%)
Status of ESBL production
NON-ESBL N (%) ESBL N (%)
E.coli 82 (50.3) 62(38.0) 20 ( 12.3)
K.pneumoniae 60 (36.8) 36(22.1) 24 (14.7)
K.ozenae 2 (1.2) 0(0.0) 2 (1.2 )
P.mirabilis 5 (3.1) 1(0.6) 4 ( 2.4)
E.cloceae 4 (2.5) 3(1.8) 1(0.6)
E.aerogens 5 (3.1) 3(1.8) 2 (1.2)
Citrobacter 3 ( 1.8) 1(0.6) 2 (1.2)
Providencia stuart 2 (1.2) 0(0.0) 2 (1.2)
Total 163(100.0) 106 ( 27.6) 57( 14.8)
ESBL producing entrobacteriaceae,57(14.8%) were isolated from bed side table, bed
frame, sink, wastewater, waiting chair, door handles, floor and wall except cafe chair.
However, Non-ESBL producing entrobacteriaceae 106(27.6%) were isolated in all
selected hospital environment sample (table 3).
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Table3. The distribution of entrobacteriaceae in different hospital environmental
samples at the University of Gondar Referral Hospital, Northwest Ethiopia, January to
June2014.
Type of Sample
Distribution of Entrobacteriaceae
Non ESBL
Producing N (%)
ESBL Producing
N (%)
Total N (%)
Floor  (n=69) 22(31.9) 3( 4.3 ) 25 (36.2)
Bed frame n=69) 20(28.9) 9(13.0) 29  (42.0)
Door Handles (n=34) 18(52.9) 1(2.9) 19(55.9)
Bed side table (n=70) 14(20) 13(18.6) 27(38.6)
Sink (n=22) 9(40.9) 13(59) 22(100.0)
Wall (n=69) 9(13) 2(2.9) 11(15.9)
Waiting chair (n=31) 4(12.9) 2(6.4) 6(19.3)
Waste water (n=15) 6(40) 9(60) 15(100)
Cafe chair (n=5) 2(40) 0(0.0) 2(1.2)
Total (n=384) 106(65.0) 57(35.0) 163(100.0)
6.2. Distribution of ESBL producing entrobacteriaceae in the hospital environment
ESBL producing entrobactewriaceae namely E.coli, K.pneumoniae, K.ozane, P.mirabilis,
E.cloceae, E.aerogens, Citrobacter and providencia stuarti were isolated from the
samples.Of these the predominant ESBL producing Entrobacteriaceae was
K.pneumoniae, 24(4.7%) followed by E.coli, 20(12.3%) and P.mirabilis 4(2.4%). E.coli
20(12.3%) and K.pneumoniae 24(14.7%) were distributed in all selected type of samples.
However, K.ozenae 2(1.2%) in sink, P.mirabilis 4(2.4%) in bed frame, floor & sink,
E.cloace, 1(0.6%) in bed frame, E. aerogens, 2(1.2%) in bed table & bed frame,
Citrobacter, 2(1.2%) in floor & sink and P.stuarti, 2(1.2%) in bed frame & sink were
found (Table3).
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Of the 57 ESBL producing entrobacteriaceae, the highest number of isolates were
recovered from waste water 9 (60%), sink 13(59%), and bed table 13(18.6%). ESBL
producing organism found in bed frame, floor, wall, cafe chair, door handles waiting
chair are less than 5% each. However, ESBL producing entrobacteriaceae were not
isolated from hospital cafe chairs (table3).
Table4. Profile of ESBL producing entrobacteriaceae in different hospital
environmental samples at University of Gondar Referral Hospital, January to   June
2014.
The highest proportion of ESBL producing entrobacteriaceae were isolated from sewage
14(93.3%)   followed by medical ward 30 (15.9%) and surgical ward 6 (11.5%) (Table5).
ESBL producing
entrobacteriacea
e
Type of sample
Bed
side
table
N=70
Bed
frame
N=69
Floor
N=69
Wall
N=69
Door
handler
N=34
Waiting
Chair
N=31
Sink
N=22
Waste
water
N=15
Cafe
Chair
N=5
E.coli 3
(4.3)
3
(4.3)
1
(14)
1
(1.4)
1
(2.9)
1
(3.2)
3
(13.6)
7
(46.7)
0
(0.0)
K.pneumoniae 8
(11.4)
2
(2.9)
1
(1.4)
1
(1.4)
0
(0.0)
1
(3.2)
4
(18.1)
7
(46.7)
0
(0.0)
K.ozenae 0
(0.0)
0
(0.0)
0
(0.0)
0
(0.0)
0
(0.0)
0
(0.0)
2
(3.5)
0
(0.0)
0
(0.0)
P.mirabilis 1
(1.4)
1
(1.4)
0
(0.0)
0
(0.0)
0
(0.0)
0
(0.0)
2
(9.0)
0
(0.0)
0
(0.0)
E.cloace 0
(0.0)
1
(1.4)
0
(0.0)
0
(0.0)
0
(0.0)
0
(0.0)
0
(0.0)
0
(0.0)
0
(0.0)
E.aerogens 1
(1.4)
1
(1.4)
0
(0.0)
0
(0.0)
0
(0.0)
0
(0.0)
0
(0.0)
0
(0.0)
0
(0.0)
Citrobacter 0
(0.0)
0
(0.0)
1
(1.4)
0
(0.0)
0
(0.0)
0
(0.0)
1
(1.8)
0
(0.0)
0
(0.0)
p.stuart 0
(0.0)
1
(1.4)
0
(0.0)
0
(0.0)
0
(0.0)
0
(0.0)
1
(4.5)
0
(0.0)
0
(0.0)
Sum=57 13
(22.8)
9
(13.0)
3
(4.3)
2
(2.9)
1
(2.9)
2
(3.5)
13
(59.0)
14
(93.3
0
(0.0)
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Table5. Distribution of ESBL producing Entrobacteriaceae in different sites of hospital
environment at University of Gondar Referral Hospital, Northwest Ethiopia, January to
June2014.
Bacterial
isolates
Site of environmental sample
Medical
Ward
N=188
Surgical
ward
N=70
Gyn-obs
ward
N=52
Fistula
clinic
N=29
Eye Clinic
N=25
Sewage
N=15
Cafe
N=5
E.coli 12
(6.3)
1
(1.4)
0
(0.0)
0
(0.0)
0
(0.0)
7
(46.7)
0
(0.0)
K.pneumoniae 14
(7.4)
1
(1.4)
1
(1.9)
0
(0.0)
1
(4.0)
7
(46.7)
0
(0.0)
K.ozenae 1
(0.5)
1
(1.4)
0
(0.0)
0
(0.0)
0
(0.0)
0
(0.0)
0
(0.0)
P.mirabilis 2
(1.0)
1
(1.4)
0
(0.0)
1
(3.4)
1
(4.0)
0
(0.0)
0
(0.0)
E.colace 0
(0.0)
0
(0.0)
1
(1.9)
0
(0.0)
0
(0.0)
0
(0.0)
0
(0.0)
E.aerogens 0
(0.0)
0
(0.0)
0
(0.0)
0
(0.0)
2
(8.0)
0
(0.0)
0
(0.0)
Citrobacter
spp
1
(0.5)
1
(1.4)
0
(0.0)
0
(0.0)
0
(0.0)
0
(0.0)
0
(0.0)
P.stuart
0
(0.0)
1
(1.4)
1
(1.9)
0
(0.0)
0
(0.0)
0
(0.0)
0
(0.0)
Total
30
(15.9)
6
( 8.6)
3
( 5..8)
1
(3.4)
3
( 12.0)
14
( 93.3)
0
( 0.0  )
6.3. Antimicrobial susceptibility patterns of ESBL producing entrobacteriaceae
isolates from the hospital’s environment
The results of antimicrobial susceptibility pattern of isolates were summarized in table 6.
All ESBL producing Entrobacteriaceae were 100% resistant to cefpirome, cefpodoxime,
ceftazidime, ceftriaxone & amoxacilin with  clavulanic acid. Moreover 40( 70.2 %), 37(
64.9 % ), 24( 42.1%), 25 (43.9%), 11(19.1% ) were found to be resistant to
chloramphenicol, cotrimoxazole, norfloxacillin, ciprofloxacillin and gentamicin
respectively. Gentamicin was relatively effective against ESBL producing
entrobacteriaceae among non betalactam antibiotics (Table 6).
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All isolated K.pneumoniae and E.coli were resistant to cefpirome, cefpodoxime,
ceftazidime, ceftriaxone and amoxacilin with clavulanic acid. Moreover, majority of
K.pneumoniae was resistant to cotrimoxazole 22 (91.7%), chloramphenicol 16 (66.7%),
norfloxacilin 11 (45.8%), ciprofloxacilin 11(45.8%) and gentamicin 6(25.0%). E.coli was
also resistant to chloramphenicol 11(25.0%).cotrimoxazole 7(35.0%), norfloxacilin
5(25.0%), ciprofloxacilin 6(30.0%), and gentamicin 4(20.0%).
All isolates of P. mirabilis were resistant to cefpirome, cefpodoxime, ceftazidime;
ceftriaxone, augmentin and chloramphenicol. Of the total of 4 ESBL producing
P.mirabilis, only one strain was resistant to norfloxacilin , ciprofloxacilin and
cotrimoxazole . However, all isolates of P.mirabilis were susceptible to gentamicin .
All isolates of K. ozenae were resistance cefpirome, cefpodoxime, ceftazidime;
ceftriaxone, amoxacillin with clavulanic acid, chloramphenicol and cotrimoxazole.
However, all isolates of K.ozenae were sensitive to norfloxacilin, ciprofloxacilin and
gentamicin.
Entrobacter cloceae and Entrobacter aerogens showed resistance 1(100%) and 2(100%)
to cefpirome, cefpodoxime, ceftazidime; ceftriaxone, amoxacilin with clavulanic acid,
ciprofloxacilin, norfloxacilin, chloramphenicol and cotrimoxazole, whereas 1(100%) and
2(100%) of the isolates of E.cloceae were sensitive to gentamicin.
All isolates of citrobacter were resistant to cefpirome, cefpodoxime, ceftazidime
ceftriaxone, augmentin, chloramphenicol, cotrimoxazole, norfloxacilin, ciprofloxacilin
and all isolates of citrobacter were sensitive to gentamicin.
Providencia stuart showed high level of resistance to 2(100%) cefpirome, cefpodoxime,
ceftazidime, ceftriaxone, amoxacilin with clavulanic acid, cotrimoxazole, norfloxacilin,
ciprofloxacilin and chloramphenicol and 1(50.0%) isolates  of p.stuart were sensitive to
gentamicin.
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Table6: Antimicrobial susceptibility pattern of ESBL producing entrobactereceae isolated
from hospital environment at University of Gondar Referral Hospital, Northwest
Ethiopia, January to June2014.
Organism
Pa
tt
er
n Antimicrobial agent’s n (%)
CFP CPD CAZ CTR CIP NX GEN C AMC SXT
E.coli
S 0(0.0)
0
(0.0)
0
(0.0)
0
(0.0)
14
(70.0)
15
(75.0)
16
(80.0)
9
(45.0)
0
(0.0)
13
(65.0)
R 20(100)
20
(100)
20
(100)
20
(100)
6
(30.0)
5
(25.0)
4
(20.0)
11
(55.0)
20
(100)
7
(35.0)
K.pneumonea
S 0(0.0)
0
(0.0)
0
(0.0)
0
(0.0)
13
(54.2)
13
(54.2)
18
(75.0)
8
(33.3)
0
(0.0)
2
(8.3)
R 24(100)
24
(100)
24
(100)
24
(100)
11
(45.8)
11
(45.8)
6
(25.0)
16
(66.7)
24
(100)
22
(91.7)
K.ozenae
S 0(0.0)
0
(0.0)
0
(0.0)
0
(0.0)
2
(100.0)
2
(100.0)
2
(100.0)
0
(0.0)
0
(0.0)
0
(0.0)
R 2
(100)
2
(100)
2
(100)
2
(100)
0
(0.0)
0
(0.0)
0
(0.0)
2
(100)
2
(100)
2
(100)
P.mirabilis
S 0(0.0)
0
(0.0)
0
(0.0)
0
(0.0)
3
(75.0)
3
(75.0)
4
(100)
0
(0.0)
0
(0.0)
2
(50.0)
R 4(100)
4
(100)
4
(100)
4
(100)
1
(25.0)
1
(25.0)
0
(0.0)
4
(100)
4
(100)
2
(50.0)
E.cloace
S
0
(0.0)
0
(0.0)
0
(0.0)
0
(0.0)
0
(0.0)
0
(0.0)
1
(100)
0
(0.0)
0
(0.0)
0
(0.0)
R 1(100)
1
(100)
1
(100)
1
(100)
1
(100)
1
(100)
0
(0.0)
1
(100)
1
(100)
1
(100)
E.aerogens
S
0
(0.0)
0
(0.0)
0
(0.0)
0
(0.0)
0
(0.0)
0
(0.0)
2
(100)
0
(0.0)
0
(0.0)
0
(0.0)
R 2(100)
2
(100)
2
(100)
2
(100)
2
(100)
2
(100)
0
(0.0)
2
(100)
2
(100)
2
(100)
Citrobacter
S
0
(0.0)
0
(0.0)
0
(0.0)
0
(0.0)
0
(0.0)
0
(0.0)
2
(100)
0
(0.0)
0
(0.0)
0
(0.0)
R 2(100)
2
(100)
2
(100)
2
(100)
2
(100)
2
(100)
0
(0.0)
2
(100)
2
(100)
2
(100)
P.stuart
S
0
(0.0)
0
(0.0)
0
(0.0)
0
(0.0)
0
(0.0)
0
(0.0)
1
(50.0)
0
(0.0)
0
(0.0)
0
(0.0)
R 2(100)
2
(100)
2
(100)
2
(100)
2
(100)
2
(100)
1
(50.0)
2
(100)
2
(100)
2
(100)
Total(57) S 0(0%)
0
(0%)
0
(0%)
0
(0%)
32
(56.1%)
33
(57.9%)
46
(80.7%)
18
(31.6%)
0
(0.0%)
17
(29.8%)
R 57(100%)
57
(100%)
57
(100%)
57
(100%)
25
(43.9%)
24
(42.1%)
11
(19.3%)
39
(68.4%)
57
(100%)
40
(70.2%)
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CFP- cefpirome, CPD-cefpodoxime, CAZ- ceftazidime, CTR- ceftriaxone, CIP-
ciprofloxacilin,  NX- norfloxacilin,  GEN- gentamicine,  C- chloramphenicol,  AMC-
augmentin, SXT- Sulfamethoxazol/Trimethoprime, S-Sensitive and R- Resistance.
6.4. Multiple antibiotics resistant
More than fifty six percent of ESBL producing entrobacteriaceae isolates were
demonstrated multiple non beta lactam antibiotics resistance against ciprofloxacilin,
norfloxacilin, gentamicin, chloramphenicol,  amoxacillin with clavulanic acid  and
cotrimoxazole.The most com,mon multiple drug resistance  isolates  were K .pneumonia
14(58%) and E.coli 8(40%). Despite the number of isolates are small isolates, E.cloceae,
E.aerogens,Citrobacter and P.stuarti were multidrug resistance (Table 7).
Table7. Multiple non-beta-lactam antibiotic resistance pattern of ESBL-producing
entrobacteriaceae isolated from hospital environment at Gondar University Referral
hospital, Northwest Ethiopia, January to June2014.
ESBL producing
entrobacteriaceae
Total Antibiogram pattern
R0 R1 R2 R3 R4 R5 MDR
E. coli 20 8(40) 4(20) 3(15) 2(10) 0(0) 3(15) 8(40)
K. pneumonia 24 2(8.3) 8(33.3) 3(12.5) 6(25) 2(8.3) 3(12.5) 14(58)
K. ozenae 2 0(0.0) 0(0.0) 2(100) 0(0.0) 0(0.0) 0(0.0) 2(100)
P.mirabilis 4 0(0.0) 3(75) 0(0.0) 0(0.0) 1(25) 0(0.0%) 1(25)
E. clocea 1 0(0.0) 0(0.0) 00.0) 0(0.0) 1(100) 0(0.0%) 1(100)
E.aerogens 2 0(0.0) 0(0.0) 0(0.0) 1(50) 1(50) 0(0.0) 2(100)
Citrobacter 2 0(0.0) 0(0.0) 0(0.0) 0(0.0) 2(100) 0(0.0) 2(100)
P. stuart 2 0(0.0) 0(0.0) 0(0.0) 0(0.0) 2(100) 0(0.0) 2(100)
Total 57(14.84) 10(1.8) 15(26.3) 8(14.0) 9(15.8) 9(15.8) 6(10.5) 32(56.1)
R0 = All susceptible, R1-R5 = Resistance to 1-5 antibiotics respectively
MDR= Multiple Drug Resistant
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7. DISCUSSION
This study demonstrates the presence of ESBL producing entrobacteriaceae at the
University of Gondar Referral Hospital environment. In many developing countries,
including Ethiopia, routine ESBL detection is not commonly carried out. Thus,
assessment of the distribution of the ESBL producing bacteria is very important to
develop guideline in the management of infections associated with such organisms.
According to the present study, the total entrobacteriaceae were 42.5%. The predominant
isolate was E.coli (50.3%) and Klebsiella pneumonia (36.8%), this is higher than the
study done in Nigeria E.coli (7.15%), Klebsiella pneumonia (5.3%). This may be due to
difference in type of health care activities and infection control practice. However, the
prevalence of Proteus mirabilis (3.1%) and Entrobacter aerogens (3.1%) are in line with
the study done in Nigeria (3.5%) and (3.5%), respectively (16). Moreover, the result of
the present study is higher than studies from Ethiopia, Gondar Hospital, Klebsiella
pneumonia (26.8%), Escherichia coli (24.3%), but   lower in Entrobacter spp. (9.8%)
and Proteus spp. (12.2%) (17). Although, the study area is the same, there is a
discrepancy in the result this may be due to difference in sample size and type of sample,
season of collection and type of patients who attend to the hospital.
The total isolates of Enterobacteriaceae from waste water were 24.6%, being the only
isolates were K.pneumoniae (12.3%) and E.coli (12.3%). The same area, which was done
in sewage system of the University of Gondar hospital showed that high prevalence of K.
pneumoniae (22.9%) and E.coli (10.4%) (24). This result variation may be due to
improvement of sanitation system in the hospital.
Regarding the ESBL producing entrobacteriaceae, the predominant ESBL producing
species was K. Pneumoniae (14.7%). This is in line from studies in Alexanderia, Egypt
(14.9%) (28) but, lower than the study done in France (37%) and Algeria (44.5%) (18,
21) and Upper Egypt (56.25%) (22,). This result variation may be due to the way of
infection prevention activities and the overall sanitation activities of the sites.
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The second predominant ESBL producing organism was E. coli (12.3%) which was
higher than the study done in France (5%), Algeria (4%) (18, 21). However, this finding
is lower as compared to the reports from Alexanderia, Egypt (85%) and Upper Egypt
(43.75%) (28, 22).These result differences may be due to difference in type of health care
activities and infection control practice in the hospital. E. cloaca (1.2%) is lower than
Algeria’s finding in intensive care unit of the hospital (11%) (21)
Another study which was done in Egypt, Zagazig University Hospital, showed the
distribution of ESBL producing entrobacteriacae, specifically K.pneumoniae 2.3%. if the
type of sample is different to the current study, the prevalence is lower than the current
finding (14.7%) (23).
According to the study, the inanimate objects in hospital OPD (Out Patient Department),
wards, surgery room, Delivery room, diagnosis section, waiting area and waste water in
different sewage system of the hospital were variously contaminated by multiple drug
resistance ESBL producing bacteria. Moreover sewage 14(93.3%) had high rate of
ESBL producing entrobacteriaceae followed by medical department 30(15.9%), Eye
clinic 3 (12.0%), Surgery 6 (8.6%), Gynacology & Obstetrics 3 (5.8%), and Fistula clinic
1 (3.4%). The overall distribution of ESBL producing Enterobacteriaceae in different
section was higher than the report in France (18). This may be due to the amount of
patient attends in each section. The value of ESBL producing organism in different sites
is directly related to the type of sample.
When observing the current study and other studies, hospital environment contamination
is caused mostly by ESBL producing K.pneumoniae than ESBL producing E.coli in
entrobacteriaceae family (19). Different studies show that the proportion of organism
which causes environmental contamination is directly associated to the patient cases and
other studies said that   the transmission rate of ESBL producing K.pneumoniae is higher
than the ESBL producing E.coli. So in the current study most patient cases can be related
to K.pneumoniae because it is the highest ESBL organism (18.19, 20).
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The antimicrobial susceptibility test showed different percentage of resistance among
ESBL producing entrobacteriaceae. All isolates of ESBL producing entrobacteriaceae
were 100% resistant to cefpirome,  cefpodoxime,  ceftazidime,  ceftriaxone &
amoxicillin with clavulanic acid. Moreover. the present study was much higher than
reports from Poland cefpodoxime (73.5%), and ceftazidime (81.6%) (26) and Upper
Egypt, K.pneumoniae ( 95.5%) for ceftazidime  and E.coli (91.4%) for ceftazidime
(20).
Even though the rate of resistance was low for non beta lactam antibiotics compared to
beta lactam antibiotics, ESBL producing entrobacteriaceae demonstrated alarming rate of
resistance, which can serve as an alternative choices for resistant strains. More than half
of K.pneumoniae and E.coli were resistant to chloramphenicol ,cotrimoxazole,
norfloxacilin, gentamicin and ciprofloxacilin whish were commonly used antibiotics.
K.pneumoniae developed resistant rates of 25.0% and 45.8% for gentamicin and
ciprofloxacilin, respectively, which was lower than studies in Upper Egypt (84.4%,
gentamicin and 77.7% ciprofloxacilin) (20). E.coli isolates also showed almost the same
pattern of resistance 20% for gentamicin and 30% for ciprofloxacilin. Low isolation rate
compared to similar study in Upper Egypt (42.8% gentamicin and 68.5% ciprofloxacilin)
(20).
The most challenging things in management of infectious disease associated with ESBL
producing entrobacteriaceae are development of multiple drug resistant (Resistant to two
or more drugs). There is different report of co-resistance in case of ESBL producing
entrobacteriaceae, but it is not more than three antibiotics (22). However, this study
shows high frequency of multiple antibiotics resistance to the commonly used antibiotics.
This might be a reflection of in appropriate use of antimicrobials, lack of laboratory
diagnostic tests, unavailability of guideline for the selection of antibiotics, that is, some
antibiotics are commonly used.
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8. LIMITATION OF THE STUDY
The limitation of this study was that ESBL   producers were isolated only by phenotypic
method. It would have been good if the genetic type of specific resistance was identified
using molecular technique but due to shortage of material and resource it was not done in
this study.
9. CONCLUSION
The result showed that 14.8% of entrobacteriaceae found in the hospital environment
were ESBL producing which pose a risk of its spread to the environment and subsequent
spread to human and animal exposure. The predominant ESBL producing
entrobacteriacae were found to be K.pneumonae, E.coli, P.mirabilis. In waste water, sink,
and bed tables higher number of ESBL producing entrobacteriaceae were isolated. Higher
proportion of ESBL producing entrobacteriaceae isolates were also found from sewage.
All ESBL producing entrobacteriaceae were resistant to ceftraxone, ceftazidime,
cefpirome, cefpodoxime and amoxacillin with clavulanic acid. Those ESBL producing
isolates were also showed resistance to non beta lactam antibiotics like 40(70.2%)
chloroamphenicol, 37(64.9%) cotrimozazole, 24(42.1%) norfloxacilin, 25(43.9%)
ciprofloxacilin and 11(19.1%) gentamicin.
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10. RECOMENDATION
 Proper way of infection prevention and control practices should be exercised in
the hospital environment and good hygiene activities should continuously
monitored in hospital.
 Sewage system of the hospital should be properly practice to prevent environment
contamination.
 Rational use of antibiotics should carefully practice
 Future studies are needed to identify ESBL producing entrobacteriaceae at
molecular label.
-
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12. ANNEXES
12.1. Media and biochemical test preparation
A. Hicrome Agar base
HiCrome ESBL Agar Base is chromogenic screening medium for the selective isolation
of ESBL producing organisms. It contains peptone mix and yeast extract, which serves
as the carbon and nitrogen sources. Chromogenic mixture is used to differentiate the
ESBL producing organisms on the basis of colour. HiCrome ESBL Selective
Supplement (FD278) helps in inhibition of other contaminating organisms. ESBL
producing E.coli grows as either pink or purple colonies. ESBL producing members of
the KESC group produce bluish green colonies; Proteus, Morganella and Providencia
do not utilize any chromogen resulting in colourless to light brown colonies. The media
prepared by suspend 40 grams in 1000 ml distilled water. Heat to boiling to dissolve the
medium completely, sterilize by autoclaving at 15lbs pressure (121oc) for 15 minutes,
Cool to 50OC and add rehydrated contents of two vials of Hicrome ESBL selective
supplement (FD278). Mix well and pour into sterile plates (28).
B. Mueller Hinton Agar preparation
Beef Extract and Acid Hydrolysate of Casein provide nitrogen, vitamins, carbon, and
amino acids in Mueller Hinton Agar. Starch is added to absorb any toxic metabolites
produced. Agar is the solidifying agent. A suitable medium is essential for testing the
susceptibility of microorganisms to cefpirome(30µg), ceftazidime(30µg),cefpodoxime
(10µg) and ceftriaxone (30µg), And also ciprofloxacin (5µg),
sulfamethoxazol/trimethoprim (1.25/23.75µg), norfloxacin (5µg) and gentamicin(10 µg),
chloramphenicol (30µg). Muller Hinton Agar is used in antimicrobial susceptibility
testing by the disk diffusion method and the zone of inhibition is considered as the
minimum concentration that inhibits the target organism.
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C. Preparation of biochemical tests
Biochemical tests are used to differentiate different organisms based on their genus and
species characteristics. Biochemical tests are performed on pure culture. At time of
prepared the sterility should be checked. Biochemical tests are TSI, MIU, Simmon
Citrate and Urea.
12.2. Data collection form
A. Sample is inanimate sample
1. Source (object) where sample taken ----------------------------------------------------
Specific ward............................................................................................
2. Code number-------------------------------------------------------------------------------
3. Media used --------------------------------------------------------------------------------
4. Organism isolated -------------------------------------------------------------------------
5. Drug susceptibility pattern
5.1. Sensitive to ----------------------------------------------------------------------
5.2. Resistance to-----------------------------------------------------------------------
5.3. Intermediate to---------------------------------------------------------------------
6. Other remarks -----------------------------------------------------------------------------
B. Waste water from hospital sewage
1. Source where sample taken...........................................................................
2. Code number................................................................................................
3. Media used...................................................................................................
4. Organism isolated........................................................................................
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5. Drug susceptibility......................................................................................
5.1. Sensitive to.....................................................................................
5.2. Resistance to....................................................................................
5.3. Intermediate to............................................................................
6. Other Remarks......................................................................................
12.3. Collection and processing of environmental samples
A. Collection of Sample in inanimate objects
1. Environmental samples was taken from inanimate objects in Intensive Care unit,
medical, orthopedic, gynecologic, obstetric, ophthalmologic, pediatric, emergency
room, reception area, Laboratory, Pharmacy and café  room.
2. Using sterile cotton tipped applicator sticks moistened with normal saline collect
sample from the surface of the object.
3. Role the swab over the surface of object on 10 by 10cm square was sampled with five
longitudinal and five latitudinal (19).
4. Label the sample as soon as possible with the name of the site and type of inanimate
object.
5. Inoculate the   specimen in to prepared MacConkey media aseptically.
6.  Inoculate the growth colonies in to biochemical test to differentiate the species
7. Then inoculate the growth colonies in to prepared Hicrome agar base aseptically to
know whether the organism is ESBL or not.
8. Incubate the plate aerobically at 35-37 oC for 24-48 hours.
9. Examine and report the culture; look for colony characteristics (color of colonies)
and perform biochemical test (MIU, Simmon citrate, SIM and TSI).
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10. Determine drug susceptibility pattern of the isolated organism.
B. Collection of waste water from sewage of the hospital
1. Waste water was collected from hospital associated sewage.
2. The waste water was collected using sterile container and label the site of collected
3. Inoculate loop full waste water in to prepared MacConkey media aseptically.
4.  Inoculate the growth colonies in to biochemical test to differentiate the species
5. Then inoculate the growth colonies in to prepared Hicrome agar base aseptically to
know whether the organism is ESBL or not
6. Inoculate the plate aerobically at 35-37oc for 24-48 hr.
7. Examine and report the culture; look for colony characteristics (color of colonies) and
perform biochemical test (MIU, Simmon citrate, SIM and TSI).
8. Determine drug susceptibility pattern of the isolated organism.
C. Biochemical testing procedure
Extended spectrum beta lactamase producing entrobacteriaceae species is identified
based on glucose and lactose fermentation, H2S production, indole formation from
tryptophan, production of acetylmethyl carbinol from glucose, liquification of gelatin, use
of citrate as a carbon source, Hydrolysis of urea and decarboxylation of amino acids.
MIU, Simmon citrate, TSI and biochemical test was used.
1. Motility Indole Urea (MIU)
Motility indole urea is a composite medium containing tryptone, phenol red, urea and a
paper strip moistened in kovac’s reagent. It used to differentiate entrobacteriaceae by
urea, motility and indole characteristics.
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Procedure
1. Prepared MIU and dispense in sterile test tube and incubate at 37oc over night.
2. Prepare a suspension of the test organism by emulsifying several colony of the
organism in a   small volume of nutrient broth.
3.  Take sample from the suspension by straight wire.
4.  Inoculate by straight wire through the centre of the medium.
5. Incubate the plate aerobically at 35-37oC for 18-24 hours.
6. Interpretation:
 Non-motile organism grow only in the line of the inoculums,
 Motile organism grow throughout the medium which become turbid
 Urease positive organism   turns the medium red
 Indole positive organisms turn the Kovac’s strips red
1. Simmon Citrate
This test is used to differentiate species of the family enterobacteriaceae. It is selective
for bacteria that have the ability to consume citrate as its sole source of carbon and
ammonium as sole nitrogen source.
Procedure
1. Prepare slopes of the medium in the sterile test tube
2. Using a sterile straight wire, first streak the slope with suspension of the test organism
and then stab the butt.
3. Incubate at 35-37oc for 48 hours
4. Interpretation
Bright blue------------positive citrate test (klebsiella,protus,salmonella,citrobacter
species)
No change in color of medium-------Negative citrate.
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2. Triple Sugar Iron (TSI)
Used for differentiation of entrobacteriaceae by observing fermentation of glucose,
lactose and sucrose, H2S and gas production.
Procedure
1. Prepared TSI, dispense in sterile test tube and make slant then incubate at 37oc over
night.
2. Prepare a suspension of the test organism by emulsifying several colony of the
organism in a small volume of nutrient broth.
3.  Take sample from the suspension by wire loop.
4.  Inoculate by wire loop, first streak the slope with suspension of the test organism and
then stab the butt.
5. Incubate the plate aerobically at 35-37oC for 18-24 hours.
6. Interpretations:
o Slant color red …………… does not ferment either lactose or sucrose
o Slant color yellow………….Ferments lactose and/or sucrose
o Butt color red………………no fermentation of glucose
o Butt color yellow…………. fermentation of glucose and acid produced
o Cracks in media ……………Gas formed bubbles or entire slant Pushed out of the
tube.
o Blackening …. ………………H2S has been produced
D. Antimicrobial sensitivity testing
A disc of blotting paper is impregnated with a known volume and appropriate
concentration of an antimicrobial, and this is placed on a plate of sensitivity testing agar
uniformly inoculated with the test organism. The antimicrobial diffuses from the disc into
the medium and the growth of the test organism is inhibited at a distance from a disc that
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is related to the sensitivity of the organism. Strains sensitive to the antimicrobial agent
are inhibited at a distance from the disk where as resistant strains have smaller zones of
inhibition or grow up to edge of the disc. The zone of inhibition is measured by clippers
or ruler and values are matched (compared) with the predetermined standard values and
reported as susceptible, Intermediate and resistant (32).
Procedure
1. Prepare a suspension of the test organism by emulsifying several colony of the
organism in a small volume of nutrient broth.
2. Much the turbidity of suspension with turbidity standard
3. With a sterile swab take sample from the suspension.
4. Spread the inoculum evenly over the Muller-Hinton agar plate with the swab
5. Using a sterile forceps or needle ,place the antimicrobial disc on the inoculated plate
6. Incubate the plate aerobically at 35-37oC for  18-24 hours
7. Read the test after checking that the bacterial growth is neither heavy nor light.
Measure the radius of the inhibition zone.
8. Interpret the reaction:
Sensitive    ............ zone of radius is wider or equal to the control
Intermediate   ......... zone of radius is more than three mm smaller than the control
Resistance ........... no zone of inhibition.
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